ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

New Grant Concepts Totaling $3 million a Year Approved, With New Contract, Two Recompetitions

July 10, 1987

St. Jude Considers Relocating to Washington U.

August 9, 1985

NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science

October 28, 1994

Celgene Signs CRADA With NCI For Development Of CDC-501.

June 30, 2000

In Brief: Rosenthal Names ACS President; Brown, Lynch, Mintz Win ACS Medals of Honor

November 14, 1997

NCI-Approved Trials Listed

April 28, 2006